Steven J. Skates

1989–2025 年に発表

90
論文数
20,562
被引用数
69
h 指数
87
i10 指数

被引用数

Steven J. Skates の年別被引用数1988 年: 被引用 4 件1989 年: 被引用 1 件1991 年: 被引用 4 件1992 年: 被引用 6 件1993 年: 被引用 12 件1994 年: 被引用 11 件1995 年: 被引用 18 件1996 年: 被引用 7 件1997 年: 被引用 15 件1998 年: 被引用 27 件1999 年: 被引用 24 件2000 年: 被引用 35 件2001 年: 被引用 40 件2002 年: 被引用 38 件2003 年: 被引用 62 件2004 年: 被引用 82 件2005 年: 被引用 91 件2006 年: 被引用 84 件2007 年: 被引用 84 件2008 年: 被引用 130 件2009 年: 被引用 147 件2010 年: 被引用 129 件2011 年: 被引用 219 件2012 年: 被引用 207 件2013 年: 被引用 148 件2014 年: 被引用 130 件2015 年: 被引用 117 件2016 年: 被引用 151 件2017 年: 被引用 225 件2018 年: 被引用 202 件2019 年: 被引用 625 件2020 年: 被引用 626 件2021 年: 被引用 586 件2022 年: 被引用 538 件2023 年: 被引用 368 件2024 年: 被引用 644 件2025 年: 被引用 325 件2026 年: 被引用 9 件1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,996 件、この内訳の 28.3%中国: 引用元論文 785 件、この内訳の 11.1%イギリス: 引用元論文 564 件、この内訳の 8%カナダ: 引用元論文 338 件、この内訳の 4.8%ドイツ: 引用元論文 301 件、この内訳の 4.3%イタリア: 引用元論文 266 件、この内訳の 3.8%オーストラリア: 引用元論文 205 件、この内訳の 2.9%オランダ: 引用元論文 199 件、この内訳の 2.8%スイス: 引用元論文 175 件、この内訳の 2.5%フランス: 引用元論文 160 件、この内訳の 2.3%スウェーデン: 引用元論文 143 件、この内訳の 2%スペイン: 引用元論文 141 件、この内訳の 2%
0%28.3%その他 25.2%

分野

  • Medicine49.4%
  • Biochemistry, Genetics and Molecular Biology30.6%
  • Chemistry11%
  • Immunology and Microbiology1.7%
  • Computer Science1.5%
  • Engineering1.1%
  • その他4.7%

トピック

  • Ovarian cancer diagnosis and treatment7.2%
  • Advanced Proteomics Techniques and Applications5%
  • Cancer Genomics and Diagnostics3.1%
  • Endometrial and Cervical Cancer Treatments2.4%
  • Mass Spectrometry Techniques and Applications1.9%
  • Bioinformatics and Genomic Networks1.8%
  • その他78.6%

共著者

全論文

検索で開く
  1. Ovarian Cancer Population Screening and Mortality After Long-Term Follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Obstetrical & Gynecological Survey 2021 被引用: 700

  2. Proteogenomics connects somatic mutations to signalling in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mehdi Mesri, Henry Rodriguez, Li Ding, Amanda G. Paulovich, David Fenyö, Matthew J. Ellis, Steven A. Carr - Nature 2016 被引用: 1,801

  3. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tao Liu, Bing Zhang, Akhilesh Pandey, Amanda G. Paulovich, Andrew N. Hoofnagle, D.R. Mani, Daniel W. Chan, David F. Ransohoff, David Fenyö, David L. Tabb, Douglas A. Levine, Emily S. Boja, Eric Kuhn, Forest M. White, Gordon A. Whiteley, Heng Zhu, Hui Zhang, Ie‐Ming Shih, Jasmin Bavarva, Jeffrey R. Whiteaker, Karen A. Ketchum, Karl R. Clauser, Kelly V. Ruggles, Kimberly Elburn, Linda I. Hannick, Mark A. Watson, Mauricio Oberti, Mehdi Mesri, Melinda E. Sanders, Melissa Borucki, Michael A. Gillette, M Snyder, Nathan Edwards, Negin Vatanian, Paul A. Rudnick, Peter B. McGarvey, Philip Mertins, R. Reid Townsend, Ratna R. Thangudu, Robert Rivers, Samuel Payne, Sherri R. Davies, Shuang Cai, Stephen E. Stein, Steven A. Carr, Steven J. Skates, Subha Madhavan, Tara Hiltke, Xian Chen, Yingming Zhao, Yue Wang, Zhen Zhang - Cell 2019 被引用: 862

  4. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vineet Bafna, Yue Wang, Henry Rodriguez, Emily S. Boja, Tara Hiltke, Robert Rivers, Lori J. Sokoll, Heng Zhu, Ie‐Ming Shih, Leslie Cope, Akhilesh Pandey, Bing Zhang, M Snyder, Douglas A. Levine, Richard Smith, Daniel W. Chan, Karin Rodland, Steven A. Carr, Michael A. Gillette, Karl R. Klauser, Eric Kuhn, D.R. Mani, Philipp Mertins, Karen A. Ketchum, Ratna R. Thangudu, Shuang Cai, Mauricio Oberti, Amanda G. Paulovich, Jeffrey R. Whiteaker, Nathan Edwards, Peter B. McGarvey, Subha Madhavan, Pei Wang, Daniel W. Chan, Akhilesh Pandey, Ie‐Ming Shih, Hui Zhang, Zhen Zhang, Heng Zhu, Leslie Cope, Gordon A. Whiteley, Steven J. Skates, Forest M. White, Douglas A. Levine, Emily S. Boja, Christopher R. Kinsinger, Tara Hiltke, Mehdi Mesri, Robert Rivers, Henry Rodriguez, Kenna M. Shaw, Stephen E. Stein, David Fenyö, Tao Liu, Jason McDermott, Samuel Payne, Karin Rodland, Richard Smith, Paul A. Rudnick, M Snyder, Yingming Zhao, Xian Chen, David F. Ransohoff, Andrew N. Hoofnagle, D.C. Liebler, Melinda E. Sanders, Zhiao Shi, Robbert J.C. Slebos, David L. Tabb, Bing Zhang ほか 10 名 - Cell 2016 被引用: 1,126

  5. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thi Trinh, Mark A. Watson, Rebecca Aft, Siddarth Rawal, Ashutosh Agarwal, Susan B. Kesmodel, Changhuei Yang, Cheng Shen, Fred H. Hochberg, David T. Wong, Abhijit A. Patel, Nickolas Papadopoulos, Chetan Bettegowda, Richard J. Côté, Sudhir Srivastava, Hakho Lee, Bob S. Carter, Leonora Balaj - Cell Reports Medicine 2023 被引用: 198

  6. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dustin J. Rabideau, Karina Reynolds, Ian Scott, Mourad W. Seif, Aarti Sharma, Naveena Singh, Julie Taylor, Fiona Warburton, Martin Widschwendter, Karin Williamson, Robert Woolas, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Mahesh Parmar, Steven J. Skates - The Lancet 2015 被引用: 1,102

  7. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

    著者: , , , , , , , , , - Gynecologic Oncology 2008 被引用: 866

  8. Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Forest M. White, Gordon A. Whiteley, Heng Zhu, Ie‐Ming Shih, Jasmin Bavarva, Jason McDermott, Jeffrey R. Whiteaker, Karen A. Ketchum, Karl R. Clauser, Kelly V. Ruggles, Kimberly Elburn, Li Ding, Linda I. Hannick, Lisa J. Zimmerman, Mark A. Watson, Mathangi Thiagarajan, Matthew J. Ellis, Mauricio Oberti, Mehdi Mesri, Melinda E. Sanders, Melissa Borucki, Michael A. Gillette, M Snyder, Nathan Edwards, Negin Vatanian, Paul A. Rudnick, Peter B. McGarvey, Philip Mertins, R. Reid Townsend, Ratna R. Thangudu, Richard Smith, Robert Rivers, Robert J.C. Slebos, Samuel Payne, Sherri R. Davies, Shuang Cai, Stephen E. Stein, Steven A. Carr, Steven J. Skates, Subha Madhavan, Tao Liu, Xian Chen, Yingming Zhao, Yue Wang, Zhiao Shi - Cell Reports 2020 被引用: 155

  9. Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer E. Fairman, Euihye Jung, Kshitij S. Arora, Osman H. Yilmaz, Sonia Cohen, Tatyana Sharova, Gary Chi, Bryanna L. Norden, Yuhui Song, Linda T. Nieman, Leontios Pappas, Aparna R. Parikh, Matthew R. Strickland, Ryan B. Corcoran, Tomas Mustelin, George Eng, Ömer H. Yilmaz, Ursula A. Matulonis, Andrew T. Chan, Steven J. Skates, Bo R. Rueda, Ronny Drapkin, Samuel J. Klempner, Vikram Deshpande, David T. Ting, Michael P. Rout, John LaCava, David R. Walt, Kathleen H. Burns - Cancer Discovery 2023 被引用: 85

  10. Biomarkers and Strategies for Early Detection of Ovarian Cancer

    著者: , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2020 被引用: 112

  11. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 211

  12. Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 57

  13. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Jacobs - The Lancet Oncology 2009 被引用: 834

  14. Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karina Reynolds, Alistair McGuire, Stuart Campbell, Mahesh Parmar, Steven J. Skates, Ian Jacobs - Journal of Clinical Oncology 2015 被引用: 198

  15. LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

    著者: , , , , , , , , , , , , , , , , , , , - Scientific Reports 2023 被引用: 49

  16. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Minasian, Nora Horick, Carol H. Kasten, Susan Nayfield, David S. Alberts, Dianne M. Finkelstein, Karen H. Lu - Clinical Cancer Research 2017 被引用: 139

  17. Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

    著者: , , , , , , , , , , , , , , , , , , - Gynecologic Oncology 2020 被引用: 76

  18. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stuart Campbell, Usha Menon - The Lancet Oncology 2010 被引用: 219

  19. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

    著者: , , , , , , , , , , - Gynecologic Oncology 2007 被引用: 693

  20. Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass

    著者: , , , , , , - Obstetrics and Gynecology 2011 被引用: 333

  21. Statistical Design for Biospecimen Cohort Size in Proteomics-based Biomarker Discovery and Verification Studies

    著者: , , , , , , , , , , , , , , , , , , - Journal of Proteome Research 2013 被引用: 127

  22. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial

    著者: , , , , , , , , , , , , - Health Technology Assessment 2023 被引用: 33

  23. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Henry Rodriguez, Paul A. Rudnick, Derek Smith, David L. Tabb, Tony Tegeler, Asokan Mulayath Variyath, Lorenzo J. Vega-Montoto, Åsa Wåhlander, Sofia Waldemarson, Mu Wang, Jeffrey R. Whiteaker, Lei Zhao, N. Leigh Anderson, Susan J. Fisher, D.C. Liebler, Amanda G. Paulovich, Fred E. Regnier, Paul Tempst, Steven A. Carr - Nature Biotechnology 2009 被引用: 1,037

  24. Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

    著者: , , , , , , , , - American Journal of Obstetrics and Gynecology 2010 被引用: 357